Commentary on "Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea".
作者信息
Shin Yu Seob, Lee Ki Soo, Kam Sung Chul
机构信息
Department of Urology, Jeonbuk National University Medical School, and Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.
Department of Urology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.
出版信息
Int Neurourol J. 2021 Dec;25(4):364. doi: 10.5213/inj.2142036.018. Epub 2021 Dec 31.
Abstract
摘要
相似文献
1
Commentary on "Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea".关于《韩国良性前列腺增生症的患病率及治疗模式变化》的评论
Int Neurourol J. 2021 Dec;25(4):364. doi: 10.5213/inj.2142036.018. Epub 2021 Dec 31.
2
Reply to Commentary on "Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea".对《韩国良性前列腺增生症的患病率及治疗模式变化》评论的回复
Int Neurourol J. 2021 Dec;25(4):365-366. doi: 10.5213/inj.2142062.031. Epub 2021 Dec 31.
3
Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health?良性前列腺增生症状与社会差异之间的关联：社会资本是否能促进前列腺健康？
Andrologia. 2018 Dec;50(10):e13125. doi: 10.1111/and.13125. Epub 2018 Aug 21.
4
Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea.韩国良性前列腺增生症的患病率及治疗模式变化
Int Neurourol J. 2021 Dec;25(4):347-354. doi: 10.5213/inj.2040412.206. Epub 2021 Jan 27.
5
α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database.α 受体阻滞剂与良性前列腺增生患者痴呆风险的关系：基于全国健康保险服务数据库的全国人群研究。
J Urol. 2019 Aug;202(2):362-368. doi: 10.1097/JU.0000000000000209. Epub 2019 Jul 8.
6
Benign prostatic hyperplasia in community-dwelling elderly in Korea.韩国社区居住老年人的良性前列腺增生症
Taehan Kanho Hakhoe Chi. 2005 Dec;35(8):1508-13. doi: 10.4040/jkan.2005.35.8.1508.
7
High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.在有良性前列腺增生证据的男性中，前列腺特异性抗原检测率较高。
Am J Med. 1998 Jun;104(6):517-25. doi: 10.1016/s0002-9343(98)00113-2.
8
Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?糖尿病与良性前列腺增生/下尿路症状——我们了解多少？
J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088.
9
Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.肥胖与良性前列腺增生：临床关联、新兴病因学模式与未来方向。
J Urol. 2009 Dec;182(6 Suppl):S27-31. doi: 10.1016/j.juro.2009.07.086.
10
The development of human benign prostatic hyperplasia with age.人类良性前列腺增生随年龄的发展。
J Urol. 1984 Sep;132(3):474-9. doi: 10.1016/s0022-5347(17)49698-4.
本文引用的文献
1
Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea.韩国良性前列腺增生症的患病率及治疗模式变化
Int Neurourol J. 2021 Dec;25(4):347-354. doi: 10.5213/inj.2040412.206. Epub 2021 Jan 27.
2
Effect of preoperative urethral dilatation on preventing urethral stricture after holmium laser enucleation of the prostate: A randomized controlled study.术前尿道扩张对预防钬激光前列腺剜除术后尿道狭窄的影响：一项随机对照研究。
Can Urol Assoc J. 2019 Nov;13(11):E357-E360. doi: 10.5489/cuaj.5781.
3
It's Time to Take Advantage of Robotic Assisted Simple Prostatectomy in Large Benign Prostatic Hyperplasia.是时候在大型良性前列腺增生症中利用机器人辅助单纯前列腺切除术了。
World J Mens Health. 2019 Sep;37(3):374-375. doi: 10.5534/wjmh.180106. Epub 2018 Dec 21.
Zotero 插件